Key result
SARS-CoV-2 inactivated vaccine enhances broad variant neutralization for up to 1 year post-recovery.
Why the study?
The impact of SARS-CoV-2 inactivated vaccine on broad neutralization against variants in individuals recovered from COVID-19 up to one year was unclear.
Does SARS-CoV-2 inactivated vaccine improve broad neutralization against variants in individuals recovered from COVID-19 up to one year?
Does SARS-CoV-2 inactivated vaccine improve broad neutralization against variants in individuals recovered from COVID-19 up to one year?
The SARS-CoV-2 inactivated vaccine enhances broad neutralization against variants in individuals recovered from COVID-19.
Answers are grounded in this paper and cite their sources.
May inform revaccination in recovered patients; extends hybrid immunity observations but leaves open randomized confirmation.
Since the outbreak of the coronavirus disease 2019 (COVID-19) in December 2019 [1], the continuously emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have been identif...
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2022) studied this question. The SARS-CoV-2 inactivated vaccine enhances broad neutralization against viral variants for up to one year in individuals recovered from COVID-19.
Synapse has enriched 10 related papers. Consider them for comparative context: